Healtcare
ALK Positive Lung Cancer Treatment Market

Publié sur 15 February 2019 dans “Santé & Fitness”, langue – English. 3 pages.

Description de la publication:

ALK positive lung cancer treatment is used for people suffering from lung cancer with Anaplastic Lymphoma Kinase (ALK) mutation (the EML4-ALK fusion gene). Plus

Lire

Autres publications de “Healtcare”

Voir toutes les publications

Healtcare ALK Positive Lung Cancer Treatment Market

Autres publications de “Healtcare”

Magazines connexes

Healtcare
ALK Positive Lung Cancer Treatment Market